Records containing: Vaso-occlusive Crisis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-13Non Invasive Positive Pressure Ventilation for Prevention of Acute Chest Syndrome in Sickle Cell Disease With Vaso-occlusive Crisis and Morphinic Treatment
-
CLINICAL_TRIALS study record update · 2026-01-02Hyperbaric Oxygen Therapy in Sickle Cell Pain
-
CLINICAL_TRIALS study record update · 2025-12-17An Open-label Extension Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease Who Have Participated in an Inclacumab Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-12-02A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises
-
CLINICAL_TRIALS study record update · 2025-11-21A Pilot Study of the Use of Oral Ketamine for Treatment of Vaso-Occlusive Pain in Adolescents and Young Adults
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-10-01Vaso-occlusive Crisis Incidence and Outcomes in a Pediatric Sickle Cell Population
-
CLINICAL_TRIALS study record update · 2025-09-18Pain Management of Vaso-Occlusive Crisis in Children and Young Adults With Sickle Cell Disease-Effect of Virtual Reality Technology
-
CLINICAL_TRIALS study record update · 2025-08-05Sex Hormones and Inflammatory Biomarkers in Patients With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2024-12-11A Randomized, Double-blind, Placebo-controlled, Multicenter Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises
-
CLINICAL_TRIALS study record update · 2024-11-18The Use of Intranasal (IN) Ketamine for Pain Control in Patients with Sickle Cell Disease and Vaso-occlusive Episode (VOE) in the Pediatric Emergency Department
-
CLINICAL_TRIALS study record update · 2024-07-16Nitrous Oxide for Analgesia in Sickle Cell Vaso-occlusive Crisis
-
CLINICAL_TRIALS study record update · 2023-12-26Intranasal Sufentanil for Analgesia of Severe Sickle Cell Vaso-occlusive Pain Crisis in the Pediatric Emergency Department: a Double Blind Randomized Versus Placebo Controlled Trial
-
CLINICAL_TRIALS study record update · 2022-11-02Multicentric, Double-blind, Randomised Controled Trial of Hyperbaric-oxygen Therapy (HBOT) Versus Placebo for Treating Vaso-Occlusive Crisis (VOC) in Sickle Cell Disease (SCD) After 8 Years Old
-
CLINICAL_TRIALS study record update · 2022-05-24Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2021-10-18Evaluation of Virtual Reality to Save Morphinic in the Treatment of Vaso-occlusive Seizures of Sickle Cell Patients Consulting in the Emergency Room
-
CLINICAL_TRIALS study record update · 2021-02-10An Open-Label Extension Study to Evaluate the Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2021-01-27Comparative Effectiveness of the Different Treatment Modalities for Management of Vaso-occlusive Painful Crisis in Pediatric Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2020-07-07Randomized Trial of High-dose Intravenous Methylprednisolone and Steroid Taper for Vaso-occlusive Crises in Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2020-05-13A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of GMI-1070, A Pan-Selectin Inhibitor, In Subjects Hospitalized For Sickle Cell Vaso-Occlusive Crisis
-
CLINICAL_TRIALS study record update · 2020-03-11Impact of Daily Prophylaxis Dose Anticoagulation With a Factor Xa Inhibitor (Apixaban) in Patients With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2019-10-21Effect of a Music Therapy Program on Vaso-occlusive Crisis Pain in Sickle Cell Disease Patients: A Pilot Study
-
CLINICAL_TRIALS study record update · 2017-03-24PCA for Pain Control in Adults With Sickle Cell Disease in the Emergency Department (ED) Decreases Admission Rates Over Standard Bolus Therapy
-
CLINICAL_TRIALS study record update · 2016-10-28Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC): A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial of MST-188 (Purified Poloxamer 188) Injection in Subjects With Sickle Cell Disease Experiencing Vaso Occlusive Crisis
-
CLINICAL_TRIALS study record update · 2015-02-16Randomized Double Blind Placebo Controlled Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose LMWH Versus Placebo
-
CLINICAL_TRIALS study record update · 2014-03-04A Randomized, Double-blind, Placebo-Controlled Study With Varespladib Infusion (A-001) in Subjects With Sickle Cell Disease and Vaso-Occlusive Crisis for the Prevention of Acute Chest Syndrome At-Risk Subjects.